The most powerful sacred melodies ever written, ranked and explored. #SacredMusic #Hymns #Classical Key detail in Bad Bunny’s Super Bowl outfit raises questions — "disappointed" Moderate Democrats ...

Sanofi’s investigational therapy rilzabrutinib has received breakthrough therapy designation from the FDA for the treatment of warm autoimmune hemolytic anemia. The designation is based on data from ...

Breakthroughs emerge by collapsing false constraints through integrated science and practical problem-solving. True innovation lives where deep technical insight meets ignored, convention-bound ...

The Breakthrough T1D San Francisco Gala returns for its 27th year, bringing the T1D community together for "A Magical Night Beneath the Cherry Blossoms" at the iconic San Francisco City Hall. This ...

A breakthrough personalized mRNA cancer vaccine that trains the immune system to target patients' unique tumor mutations is showing promising results. Five-year trial data show the risk of recurrence ...

Breakthrough therapy designation targets the post-CDK4/6 setting in PIK3CA-mutant HR+/HER2− advanced disease, where progression is common and therapeutic options remain constrained. Phase 1/2 ...

Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer. Notoriously aggressive and difficult to treat, pancreatic cancer is rarely ...

Please provide your email address to receive an email when new articles are posted on . FDA has granted breakthrough designation for litifilimab in patients with cutaneous lupus erythematosus. The ...

Disclosure: Our goal is to feature products and services that we think you'll find interesting and useful. If you purchase them, Entrepreneur may get a small share of the revenue from the sale from ...

Please provide your email address to receive an email when new articles are posted on . Ianalumab has received the FDA’s breakthrough therapy designation for Sjögren’s disease. Novartis plans to ...

Regulatory submission for ianalumab in Sjögren disease is expected in early 2026, according to Novartis. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...

Eli Lilly and Co. has received the U.S. Food and Drug Administration’s breakthrough therapy designation for a drug in development to treat certain ovarian cancer patients. The Indianapolis-based ...